Dihydropyridine Calcium Channel Blocker [EPC]

328392 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE ISRADIPINE NISOLDIPINE AMLODIPINE AMLODIPINE AND VALSARTAN CLEVIDIPINE CLEVIPIDINE FELODIPINE EXTENDED-RELEASE TABLETS NICARDIPINE HYDROCHLORIDE

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

# Side effect Count
0 FATIGUE 19675
1 DIARRHOEA 17906
2 DYSPNOEA 16960
3 NAUSEA 16946
4 DRUG INEFFECTIVE 15737
5 OFF LABEL USE 14736
6 DIZZINESS 13850
7 HEADACHE 13016
8 PAIN 11793
9 ACUTE KIDNEY INJURY 11589
See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEPHROGENIC ANAEMIA 1194 0.2575
1 END STAGE RENAL DISEASE 2500 0.1369
2 SHOCK 2111 0.0917
3 BLOOD PRESSURE SYSTOLIC INCREASED 1761 0.0902
4 CHRONIC KIDNEY DISEASE 6405 0.0842
5 ORTHOSTATIC HYPOTENSION 1424 0.0817
6 HYPOMAGNESAEMIA 1137 0.0816
7 VASCULITIS 951 0.0816
8 METABOLIC ACIDOSIS 2503 0.0782
9 TUBULOINTERSTITIAL NEPHRITIS 1442 0.0769
See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]